Bioinformatics prediction and mass spectrometry were used to determine the SARS-CoV-2 peptide sequences in HLA-I and HLA-II peptidomes that are specifically recognized by circulating the CD8+ and CD4+ T cells of COVID-19 patients [18,36,37,38,59]. The gene discussed is CD8A; the disease is COVID-19.